Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Principia Biopharma (United States) | Researchclopedia

Back to institutions

Principia Biopharma (United States)

South San Francisco, Californiacompany

73

Works

20,417

Citations

74

h-index

Top Research Topics

Chronic Lymphocytic Leukemia Research Autoimmune Bullous Skin Diseases Platelet Disorders and Treatments

Top Researchers

Michael D. Taylor Queen Mary University of London

1,680 works76,569 citationsh-index: 132

Recent Research

Phase I Clinical Trial Evaluating Safety, Tolerability, and Early Activity of Exarafenib (KIN-2787), a Highly Selective Pan-RAF Inhibitor, in <i>BRAF</i> -Altered Solid Tumors or <i>NRAS</i> -Mutant Melanoma

Valentina Gambardella,Meredith McKean,et al.

20261 citations

Chronic Myeloid Leukemia Treatments

Fibroblast Growth Factor Research

Lymphoma Diagnosis and Treatment

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Epigenetics and DNA Methylation

PI3K/AKT/mTOR signaling in cancer

Immunodeficiency and Autoimmune Disorders

Monoclonal and Polyclonal Antibodies Research

Hepatitis C virus research

Wei Chen North Sichuan Medical University

2,011 works33,041 citationsh-index: 78

Jin Tae Hong Qinghai University

901 works25,275 citationsh-index: 74

Charles Wang University College of the Cayman Islands

410 works13,697 citationsh-index: 53

Patrick F. Smith

496 works11,482 citationsh-index: 56

Mary E. Gerritsen Gynuity Health Projects

194 works10,709 citationsh-index: 51

First-in-human phase I study of HCB101, a 3.5th-generation CD47-SIRPα fc fusion protein: Cytopenia-sparing safety, broad pharmacologic window, and low-dose clinical activity in relapsed/refractory non-Hodgkin lymphoma

Abigail Yu,Wenyu Li,et al.

20250 citations

OR14-08 Clinical Potential of Novel Kisspeptin Receptor Agonists in Reproductive Health

Encarnacion Torres Jimenez,Isabel López,et al.

20250 citations

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice

Christopher W. Smith,Joana Campos,et al.

202414 citations

A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

Benjamin Garmezy,Mitesh J. Borad,et al.

202417 citations

Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study

Dédée F. Murrell,F. Caux,et al.

202421 citations